Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits

National and international experts still recommend Gardasil HPV vaccination, despite critics’ claims it can cause serious side effects.

In April, a federal court ordered Merck to turn over data detailing adverse events from trials of the company’s human papillomavirus vaccine, Gardasil, which is designed to lower the risk of cervical and other cancers. The move comes after plaintiffs claiming to have suffered due to the vaccine were consolidated into a Multidistrict Litigation suit, with proceedings expected to begin in the next two years.